Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: A randomized controlled trial

Liver International

Volumn 24, Issue 6, 2004, Pages 625-629

  Akamatsu, Masatoshi ^a   Yoshida, Haruhiko ^a   Obi, Shuntaro ^a   Sato, Shinpei ^a   Koike, Yukihiro ^a   Fujishima, Tomonori ^a   Tateishi, Ryosuke ^a   Imamura, Masatoshi ^a   Hamamura, Keisuke ^a   Teratani, Takuma ^a   Shiina, Shuichiro ^a   Ishikawa, Takashi ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma (HCC); Percutaneous ethanol injection therapy (PEIT); Radiofrequency ablation (RFA); Transcatheter arterial embolization (TAE)

Indexed keywords

ALCOHOL;

ABDOMINAL PAIN; ADULT; AGED; ANAMNESIS; ARTERY CATHETERIZATION; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; CATHETER ABLATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; FEVER; HEPATIC ARTERY; HUMAN; INTERMETHOD COMPARISON; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; LIVER NODULE; MALE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR RECURRENCE; VASCULAR DISEASE;

EID: 19944372023     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.0963.x     Document Type: Article

References (25)

1. El-Serag H B, Mason A C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-50.
2. Taylor-Robinson S D, Foster G R, Arora S, Hargreaves S, Thomas H C. Increase in primary laver cancer in the UK, 1979-94. Lancet 1997; 350: 1142-3.
3. Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987; 47: 4967-72.
4. Seki T, Kubota Y, Wakabayashi M, Kunieda K, Nakatani S, Shiro T, et al. Percutaneous transhepatic microwave coagulation therapy for hepatocellular carcinoma proliferating in the bile duct. Dig Dis Sci 1994; 39: 663-6.
5. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148: 397-401.
6. Shiina S, Hata Y, Niwa Y, Komatsu Y, Tanaka T, Yoshiura K, et al. Multiple-needle insertion method in percutaneous ethanol injection therapy for liver neoplasms. Gastroenterol Jpn 1991; 26: 47-50.
7. Livraghi T, Goldberg S N, Lazzaroni S, Meloni F, Solbiati L, Gazelle G S. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655-61.
8. Livraghi T, Giorgio A, Marin G, Salmi A, De Sio I, Bolondi L, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101-8.
9. Matsui O, Kadoya M, Yoshikawa J, Gabata T, Arai K, Demachi H, et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 1993; 188: 79-83.
10. Bruix J, Llovet J M, Castells A, Montana X, Bru C, Ayuso M C, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998; 27: 1578-83.
11. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. N Engl J Med 1995; 332: 1256-61.
12. Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Idobe Y, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer 2001; 92: 1516-24.
13. Tanaka K, Nakamura S, Numata K, Kondo M, Morita K, Kitamura T, et al. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998; 82: 78-85.
14. Tanaka K, Nakamura S, Numata K, Okazaki H, Endo O, Inoue S, et al. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 1992; 185: 457-60.
15. Tanaka K, Okazaki H, Nakamura S, Endo O, Inoue S, Takamura Y, et al. Hepatocellular carcinoma: treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol - injection. Radiology 1991; 179: 713-7.
16. Bartolozzi C, Lencioni R, Caramella D, Vignali C, Cioni R, Mazzeo S, et al. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 1995; 197: 812-8.
17. Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002; 62: 64-8.
18. Teratani T, Ishikawa T, Shiratori Y, Shiina S, Yoshida H, Imamura M, et al. Hepatocellular carcinoma in elderly patients: beneficial therapeutic efficacy using percutaneous ethanol injection therapy. Cancer 2002; 95: 816-23.
19. Shiina S, Yasuda H, Muto H, Tagawa K, Unuma T, Ibukuro K, et al. Percutaneous ethanol injection in the treatment of liver neoplasms. Am J Roentgenol 1987; 149: 949-52.
20. Livraghi T, Festi D, Monti F, Salmi A, Vettori C. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 1986; 161: 309-12.
21. Shiina S, Tagawa K, Unuma T, Takanashi R, Yoshiura K, Komatsu Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 1991; 68: 1524-30.
22. Hamamura K, Shiratori Y, Shiina S, Imamura M, Obi S, Sato S, et al. Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein. Cancer 2000; 88: 1557-64.
23. Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, et al. Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 2001; 91: 561-9.
24. Ishii H, Okada S, Nose H, Okusaka T, Yoshimori M, Takayama T, et al. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1996; 77: 1792-6.
25. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 488-94.